NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-209-2016-0-NZ-17 Domain Antibody Against RSV F Protein NZ National Stage 738300 Issued
NIAID E-209-2016-0-KR-14 Domain Antibody Against RSV F Protein KR National Stage 10-2018-7001595 Issued
NIAID E-209-2016-0-ZA-25 Domain Antibody Against RSV F Protein ZA National Stage 2018/00369 Issued
NCI E-549-2013-0-US-03 IMMUNOGENIC JC POLYOMAVIRUS COMPOSITIONS AND METHODS OF USE US National Stage 15/106,074 9931393 Issued PDF
NLM E-111-2016-7-PCT-01 Novel CRISPR Enzymes And Systems PCT PCT COMB PCT/US2016/038258 Expired
NLM E-110-2016-2-PCT-01 Novel CRISPR Enzymes And Systems PCT PCT COMB PCT/ US 16/038238 Expired
NLM E-110-2016-2-CA-03 Novel CRISPR Enzymes And Systems CA National Stage 3012607 Pending
NCI E-050-2014-0-US-07 Cancer Immunotherapy by Delivering Class II MHC Antigens Using A VLP-Replicon US National Stage 15/104,785 Abandoned
NIDDK E-215-2015-0-PCT-02 Non-hormonal Mammalian Sperm Decoy Contraception Based On The N-terminus Of The ZP2 Protein PCT PCT PCT/US2016/037428 Expired
NIAID E-170-2013-1-DE-07 CHIMERIC ANTIGEN RECEPTORS TO CONTROL HIV INFECTION DE EP 14812376.3 Issued
NIAID E-170-2013-1-FR-08 CHIMERIC ANTIGEN RECEPTORS TO CONTROL HIV INFECTION FR EP 14812376.3 Issued
NIAID E-170-2013-1-GB-09 CHIMERIC ANTIGEN RECEPTORS TO CONTROL HIV INFECTION GB EP 14812376.3 Issued
NCI E-267-2014-0-CN-03 PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS CN National Stage 201680034090.3 Issued
NCI E-267-2014-0-DK-11 PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS DK EP 16732426.8 Issued
NCI E-267-2014-0-SE-19 PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS SE EP 16732426.8 Issued
NCI E-267-2014-0-ES-12 PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS ES EP 16732426.8 Issued
NCI E-267-2014-0-NO-18 PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS NO EP 16732426.8 Issued
NCI E-267-2014-0-EP-04 PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS EP National Stage 16732426.8 Issued
NCI E-267-2014-0-BE-08 PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS BE EP 16732426.8 Issued
NCI E-267-2014-0-GB-14 PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS GB EP 16732426.8 Issued
NCI E-267-2014-0-CH-09 PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS CH EP 16732426.8 Issued
NCI E-267-2014-0-FR-13 PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS FR EP 16732426.8 Issued
NCI E-267-2014-0-DE-10 PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS DE EP 16732426.8 Issued
NCI E-267-2014-0-NL-17 PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS NL EP 16732426.8 Issued
NCI E-267-2014-0-IE-15 PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS IE EP 16732426.8 Issued
NCI E-267-2014-0-IT-16 PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS IT EP 16732426.8 Issued
NCI E-267-2014-0-JP-05 PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS JP National Stage 2017-563547 Issued
NIAID E-202-2015-0-PCT-02 GLUTAMINE ANTAGONISTS FOR USE IN TREATING CEREBRAL EDEMA AND CEREBRAL MALARIA PCT PCT PCT/US2016/036996 Expired
NCI E-267-2014-0-PCT-02 PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS PCT PCT PCT/US2016/036888 Expired
NCI E-047-2014-0-JP-05 Multi-Epitope TARP Peptide Vaccine And Uses Thereof JP National Stage 2016-538101 Issued
NCI E-047-2014-0-US-06 Multi-Epitope TARP PeptideTherapeutic Cancer Vaccine US National Stage 15/102,996 10286050 Issued PDF
NCI E-181-2006-0-AU-25 Micro-RNA Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Lung Cancer AU DIV 2016203848 Abandoned
NICHD E-120-2015-0-JP-18 Method For On-demand Contraception JP DIV 2016-114491 Abandoned
NIAID E-285-2002-0-US-26 LUTZOMYIA LONGIPALPIS POLYPEPTIDES AND METHODS OF USE US DIV 15/175,329 9884100 Expired PDF
NCI E-158-2009-0-US-08 GRANULYSIN IN IMMUNOTHERAPY US DIV 15/174,402 9855330 Abandoned PDF
NCI E-750-2013-0-KR-08 Method for Subtyping Lymphoma Types by Means of Expression Profiling KR National Stage 2016-7014876 Issued
NIAID E-130-2015-0-PCT-02 Neutralizing Antibodies to HIV-1 ENV and Their Use PCT PCT PCT/US2016/035791 Expired
NICHD E-223-2015-1-PCT-01 Autophagy Modulators for Treating Neurodegenerative Diseases PCT PCT COMB PCT/US16/035830 Abandoned
NCI E-125-2011-2-US-03 Antibodies And Immunotoxins Reactive With Human Gangliosides 3'6'iso-LM1 And 3'6'iso-LD1 And Methods Of Use US DIV 15/171,018 10052382 Issued PDF
NIEHS E-292-2015-0-PCT-02 Methods And Composition For Treating Nephropathy PCT PCT PCT/US16/035548 Expired
NIAAA E-282-2012-1-PCT-02 Cannabinoid Receptor Mediating Compounds PCT PCT PCT/US2016/035291 Expired
NIAAA E-282-2012-1-EP-05 Cannabinoid Receptor Mediating Compounds EP National Stage 16728547.7 Abandoned
NIDDK E-064-2004-0-JP-59 The Use Of Leptin For Treating Human Lipoatrophy JP DIV 2016-108936 Expired
NCI E-282-2016-2-TW-03 Methods For Pre-conditioning Patients For Cell Therapy TW National Stage 105116879 Issued
NCI E-150-2017-2-EP-18 Diagnostic Methods For T Cell Therapy EP National Stage 16800846.4 Issued
NCI E-150-2017-2-AU-02 Diagnostic Methods For T Cell Therapy AU National Stage 2016268863 Issued
NCI E-282-2016-2-AU-06 Methods For Pre-conditioning Patients For Cell Therapy AU National Stage 2016268864 Issued
NIDCR E-485-2013-0-US-03 Methods of Treating or Preventing Pruritis by Blocking Natriuretic Polypeptide B15/039982 US National Stage 15/039,982 9987330 Issued PDF
NCI E-282-2016-2-US-02 Methods For Pre-conditioning Patients For Cell Therapy US ORD 15/167,977 9855298 Issued PDF
NCI E-150-2017-2-PCT-01 Diagnostic Methods For T Cell Therapy PCT PCT COMB PCT/US2016/034885 Expired